APA (7th ed.) Citation

Li, L., Gu, Y., Zhang, M., Shi, X., Li, Z., Xu, X., . . . Liang, H. (2023). HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients. npj Precision Oncology, 7(1), 1. https://doi.org/10.1038/s41698-023-00402-y

Chicago Style (17th ed.) Citation

Li, Lei, et al. "HRD Effects on First-line Adjuvant Chemotherapy and PARPi Maintenance Therapy in Chinese Ovarian Cancer Patients." Npj Precision Oncology 7, no. 1 (2023): 1. https://doi.org/10.1038/s41698-023-00402-y.

MLA (9th ed.) Citation

Li, Lei, et al. "HRD Effects on First-line Adjuvant Chemotherapy and PARPi Maintenance Therapy in Chinese Ovarian Cancer Patients." Npj Precision Oncology, vol. 7, no. 1, 2023, p. 1, https://doi.org/10.1038/s41698-023-00402-y.